Korsana Biosciences (KRSA) vs First Tracks Biotherapeutics (TRAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
First Tracks Biotherapeutics is the larger company by market cap ($1.75 billion vs $1.71 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRSA | TRAX |
|---|---|---|
| Share price | $37.56 | $41.64 |
| Market cap | $1.71B | $1.75B |
| 1-day change | +5.95% | -6.34% |
| YTD return | +322.50% | — |
| 1-year return | +262.55% | — |
| 5-year return | -89.05% | — |
| EPS (TTM) | $-16.14 | $-4.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.07M | — |
| Revenue growth (YoY) | +3.70% | — |
| Net income (latest FY) | $-3.53M | — |
| Operating margin | -239.78% | — |
| Net margin | -170.11% | — |
| 52-week high | $59.36 | $54.78 |
| 52-week low | $7.19 | $14.72 |
| Distance from 52-week high | -36.73% | -23.99% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +17.15% | +80.52% |
| Average volume | 119.71K | 826.70K |
| Shares outstanding | 45.54M | 42.02M |
| Employees | 19 | 104 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Korsana Biosciences
KRSA stock →Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 19 employees
About First Tracks Biotherapeutics
TRAX stock →First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees
KRSA vs TRAX FAQ
Which is bigger, Korsana Biosciences or First Tracks Biotherapeutics?
First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.75B compared with $1.71B for Korsana Biosciences (KRSA).
Are Korsana Biosciences and First Tracks Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.